NUCLEAR MEDICINE

UAE International Nuclear Medicine Conference recommends expanding use of modern technologies in cancer treatment

Batoul Al Balooshi, Assistant Professor of Nuclear Medicine at Mohammed Bin Rashid University of Medicine and Health Sciences, Head of the Department of Nuclear Medicine at the Dubai Health Authority, and President of the Arab Society for Nuclear Medicine, said, "Today we are witnessing a major shift in how we deal with some types of cancer that did not respond to conventional chemotherapy or radiation, and through advanced nuclear medicine techniques, we were able to treat 15 patients from inside and outside the country with prostate tumours and endocrine tumours of the final control of tumours in all cases."

More in NUCLEAR MEDICINE

Nagpur : Rs76cr sanctioned for GMCH radiotherapy dept

As per the GR dated March 6, 2019, the government has allocated Rs76.10 crore for construction. However, for the first time, the government has selected NIT for construction work instead of PWD.
Tamil Nadu: State told to assess PET-CT scanner need in govt hospitals

The Madurai bench of the Madras high court has directed the state government to assess and submit a report regarding the requirement of Positron emission tomography - computed tomography (PET-CT) equipment in all district headquarters hospitals in the state.
PGI reduces cost of test for brain tumour patients from Rs 7,000 to Rs 500

The department of nuclear medicine at the PGI has developed a nuclear test which has reduced its cost from Rs 7,000 per month to Rs 500 per month.
The future is moving to a very cancer specific research molecule: Dr Sachin Gawde

Shahid Akhter, editor, ETHealthworld spoke to Dr Sachin Gawde, Consultant Nuclear medicine and Pet CT expert, HCG Apex Cancer Centre, Mumbai, to know about the advancements in Pet CT driven by specific molecules in different stages of onco-treatment.
Besides newer isotopes, nuclear medicine is all set to revolutionize the diagnostics and therapeutic capabilities: Dr Mythri Shankar

PET-CT could allow us to cover greater areas of treatment or give lesser amount of radiation therefore preventing complication that could happen from radiation therapy.
Cytecare announces the appointment of Dr. Mythri Shankar as Senior Consultant – Nuclear Medicine

With over 15 years of clinical expertise, Dr. Shankar’s experience has enabled the integration of most appropriate protocol selection while performing sophisticated radioactive injection procedures.
Jubilant Life to buy Triad Isotopes' radio-pharmacy business

Jubilant Life Sciences said Triad operates the second largest radio-pharmacy network in the US with more than 50 pharmacies, distributing nuclear medicine products to the largest National GPOs, regional health systems, stand-alone imaging centres, cardiologists and hospitals.
Jubilant Life arm gets Australia TGA nod for lung scan drug

Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the Australian health regulator Therapeutic Goods Administration (TGA) for Lyophilized kit for preparation of injection used for lungs scan.
15% of clinically diagnosed parkinson patients have no disease at all: Dr Vikram Lele

The future of nuclear medicine is very bright because we have several new tracers coming up which will help us to characterize the diseases at a very early stage.
Ultra-fast detection of breast density using MRT helps determine breast cancer risks

A high breast density is an independent risk factor for breast cancer. MRT is the safest method for breast cancer diagnosis and is now used for early diagnosis.
'Benefits of Nuclear Medicine will Outweigh Costs' : Dr Vikram R Lele, Director, Nuclear Medicine, Jaslok Hospital

Nuclear medicine has made tremendous impact in the diagnosis and treatment of select group of cancers. It is possible to diagnose cancer early with its help.